Issue Archive
March 2023 | Volume 22 | Issue 3
Original Articles
WATCH VIDEO ABSTRACT: Scarring and Dyschromias in Fitzpatrick Skin Type IV-VI: A Review of Dermatologic Treatment Protocols
Importance: Managing chronic conditions is an essential aspect of dermatologic care, especially regarding the resolution of inflammatory dermatologic disease and recovery of skin lesions. Short-...
Read MoreBreaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene
Topical therapies are commonly used to treat psoriasis, either as monotherapy for milder disease or as adjuncts to systemic and biologic drugs. Topical steroids and tazarotene are both options for top...
Read MoreDevelopment and Validation of a Photonumeric Scale for Evaluation of Lip Fullness
Background: The shape, proportion, and fullness of one's lips are associated with overall facial beauty and attractiveness. Lip augmentation, due to personal preference or to reverse natural aging, ha...
Read MoreTrends in Oral Antibiotic Use for Acne Treatment: A Retrospective, Population-Based Study in the United States, 2014 to 2016
Background: Antibiotic resistance related to prolonged antibiotic use is an emerging threat to public health. Objective: To evaluate recent trends in oral antibiotic use for acne treatment.
Meth...
Read MoreTopical Anesthetic Use in Cosmetic Dermatology
In today's society, there is growing interest in outpatient cosmetic procedures. Topical anesthetics are commonly used as anesthesia for these procedures. They can be used alone or part of a multi-pro...
Read MorePatient Preference for Calcipotriene and Betamethasone Dipropionate Cream Versus Foam for the Topical Treatment of Psoriasis: A Pilot Study
Background: The well-established sequential use of topical calcipotriene and topical betamethasone dipropionate in combination has been shown to provide greater benefit than either monotherapy. A newe...
Read MoreManaging Monkeypox Virus: Characterizing Common Cutaneous Manifestations and Antiviral Efficacy
Background: The Monkeypox virus (MPX) has been detected in multiple non-endemic countries since May 2022. The cutaneous manifestations of MPX can have multiple distinct presentations, including pustul...
Read MoreTopical Minoxidil Adherence in Patients With Alopecia
Background: Non-adherence to topical minoxidil in alopecia patients is a barrier to efficacy. Understanding patient factors associated with adherence and non-adherence may provide actionable targets t...
Read MoreMelatonin and the Human Hair Follicle
Background: Melatonin, a pleiotropic hormone, affects the physiological processes including that of the hair follicle. We seek to identify the scientific evidence to support the potential benefits of ...
Read More
Features
Evaluating Sentiment, Engagement, and Perception of Biologics Among Patients with Psoriasis and Psoriatic Arthritis on Reddit
Background: Limited analyses of social media content among psoriasis (PsO) and psoriatic arthritis (PsA) patients exist. These patients may turn to social media to gain insight into treatments such as...
Read MoreDermTok: How TikTok Is Changing the Landscape of Dermatology Patient Education
Background: TikTok gives its users a platform to share and view short videos on a wide range of topics, including dermatology related topics. This project sought to analyze the sources of TikTok video...
Read MoreUtilization Management Barriers Among Patients With Cicatricial Alopecia
Citation: Rypka K, Pathoulas J, Wharton K, et al. Utilization management barriers among patients with cicatricial alopecia. J Drugs Dermatol. 2023;22(3):312-314. doi:10.36849/JDD.6842...
Read MoreSkin of Color Representation in Clinical Trials: An Analysis of Clinicaltrials.gov From 2008-2022
There is a plethora of dermatologic clinical trials; however, little is known regarding the representation of skin of color (SOC) populations. We evaluated the 15 most prevalent skin conditions in SOC...
Read More
Case Reports
Reversal of Stress-Associated Alopecia
Novel coronavirus SARS-CoV-2, designated as COVID-19 by the World Health Organization (WHO) on February 11, 2020, is one of the highly pathogenic β-coronaviruses that infects humans.1 Alopecia ar...
Read MoreSuccessful Management of Erythema Dyschromicum Perstans Following Topical Ruxolitinib Therapy
Erythema dyschromicum perstans (EDP) is a rare cutaneous disorder in which patients develop gray or blue-brown macules or patches on their bodies.1 This condition does not appear to have a gender or a...
Read More
